Rocky Mountain Perfusion and the Quest Myocardial Protection System (EP Video)

We tested whether administration of FK633, a short-acting glycoprotein IIb/IIIa inhibitor, before median sternotomy and cardiopulmonary bypass was able to interrupt the platelet activation loop and thereby preserve platelet number and function.

In this article, we discuss the clinical approach and management of pulmonary arterial hypertension (PAH) from the perspective of a single US-based academic institution.